Author

S. Shalapour

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1

Frequent Co-Authors

M. Karin· 2 shared A. J. Rundberg Nilsson· 1 shared A. M. Dyevoich· 1 shared A. M. Sockwell· 1 shared A. Nguyen· 1 shared A. O. Kaseb· 1 shared B. Li· 1 shared H. Sugimoto· 1 shared

Activity by Year

2023-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

M. Karin

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMar 5, 2023

Antigen-presenting type-I conventional dendritic cells facilitate curative checkpoint blockade immunotherapy in pancreatic cancer

K. K. Mahadevan, A. M. Dyevoich, Y. Chen…·R. Kalluri

The paper shows that type-I conventional dendritic cells enhance checkpoint blockade immunotherapy effectiveness in pancreatic cancer when combined with pancreatitis.

DOI 10.1101/2023.03.05.531191

mousebulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMar 5, 2023

Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells

L. Gu, Y. Zhu, M. Lee…·S. Shalapour

This study shows that losartan, an angiotensin II receptor inhibitor, reduces liver fibrosis and enhances T cell infiltration in HCC, improving response to PD-1 blockade.

DOI 10.1101/2023.03.05.531188

mouseexperimental assay

𝕏 PostBluesky

Cell BiologybioRxivJan 24, 2023

IRF1 regulates self-renewal and stress-responsiveness to support hematopoietic stem cell maintenance

A. J. Rundberg Nilsson, H. Xian, S. Shalapour…·M. Karin

This study identifies IRF1 as a master regulator of hematopoietic stem cell (HSC) self-renewal and stress responses, showing its role in maintaining HSC function and its relevance in AML patient stratification.

DOI 10.1126/sciadv.adg5391

mousebulk RNA-seq

𝕏 PostBluesky